Assertio Holdings (ASRT) announced that Mark Reisenauer has been appointed as an independent director to the Company’s Board of Directors. Mr. Reisenauer will serve as a member of the Compensation Committee. He previously served as President of U.S. Commercial at Astellas Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASRT:
- Assertio Holdings announces results of Rolvedon injection study
- Assertio Holdings appoints Schwichtenberg as CTO, Pietrya as CCO
- Largest borrow rate increases among liquid names
- Assertio Holdings price target lowered to $2.15 from $2.75 at Alliance Global
- Assertio Therapeutics Reports Strong Q3 and Board Changes